Related content

Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation

By Wheeler Heather E   Dolan M Eileen  

Pharmacogenomics, Vol. 13, Iss. 1, 2012-01 ,pp. : 55-70

Future Medicine

Access to resources Recommend Favorite

Human lymphoblastoid cell lines: a goldmine for the biobankomics era

By Nam Hye-Young   Shim Sung-Mi   Han Bok-Ghee   Jeon Jae-Pil  

Pharmacogenomics, Vol. 12, Iss. 6, 2011-06 ,pp. : 907-917

Future Medicine

Access to resources Recommend Favorite

Cancer pharmacogenomics: do cancer cell lines have the right stuff?

By Auman J Todd  

Pharmacogenomics, Vol. 11, Iss. 8, 2010-08 ,pp. : 1035-1037

Future Medicine

Access to resources Recommend Favorite

Genome-wide transcriptomic variations of human lymphoblastoid cell lines: insights from pairwise gene-expression correlations

By Vincent Marc   Oved Keren   Morag Ayelet   Pasmanik-Chor Metsada   Oron-Karni Varda   Shomron Noam   Gurwitz David  

Pharmacogenomics, Vol. 13, Iss. 16, 2012-12 ,pp. : 1893-1904

Future Medicine

Access to resources Recommend Favorite

Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers

By Oved Keren   Morag Ayelet   Pasmanik-Chor Metsada   Oron-Karni Varda   Shomron Noam   Rehavi Moshe   Stingl Julia C   Gurwitz David  

Pharmacogenomics, Vol. 13, Iss. 10, 2012-07 ,pp. : 1129-1139

Future Medicine

Access to resources Recommend Favorite